Global Intranasal Drug Delivery Devices Market Report 2025

Intranasal Drug Delivery Devices Global Market Report 2025 – By Product (Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products), By Dosage (Unit-Dose, Multi-Dose), By Application (Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications), By End User (Hospitals, Clinics, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Intranasal Drug Delivery Devices Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Intranasal Drug Delivery Devices Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Intranasal Drug Delivery Devices Market Definition

Intranasal drug delivery devices are medical devices that deliver medications into the nasal cavity. These devices are intended to administer medications directly to the nasal mucosa, which is highly vascularized and has a huge surface area, allowing the drug to be absorbed into the bloodstream quickly. It delivers drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

The main products in intranasal drug delivery devices are powder delivery devices, liquid delivery devices, pressurized metered-dose inhalers and others. A powder delivery device refers to a type of medical or pharmaceutical device designed to administer medications. It includes unit-dose and multi-dose and is used in various applications such as chronic obstructive pulmonary disease (COPD), rhinitis, cystic fibrosis, nasal congestion, asthma and others. The end users are hospitals, clinics, homecare, and others.

Intranasal Drug Delivery Devices Market Segmentation

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, nebulizers, Nasal Sprays

Intranasal Drug Delivery Devices Market Size and growth rate 2025 to 2029: Graph

Intranasal Drug Delivery Devices Market Size 2025 And Growth Rate

The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $60.27 billion in 2024 to $65.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, market expansion in allergic rhinitis treatment, wider range of indications.

Intranasal Drug Delivery Devices Market Growth Forecast

The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $92.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, market penetration in emerging economies. Major trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, incorporation of biologics and peptides.

Intranasal Drug Delivery Devices Market Driver: Rising Prevalence of Chronic Diseases Fuels Growth In The Intranasal Drug Delivery Devices Market

The increasing prevalence of chronic diseases is expected to propel the growth of the intranasal drug delivery devices market going forward. Chronic diseases can be defined as conditions that last 1 year or more and require ongoing medical attention, limit activities of daily living, or both. Intranasal drug delivery devices are used to manage chronic diseases by providing a non-invasive and efficient way to administer medications. They allow medications to be delivered directly to the affected area, which is convenient, making IT easy to use and promoting rapid absorption. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of chronic diseases is driving the growth of the intranasal drug delivery devices market.

Intranasal Drug Delivery Devices Market Driver: Surge In Demand For Non-Invasive Drug Delivery Fuels Growth In The Intranasal Drug Delivery Device Market

The growing demand for non-invasive drug delivery methods is expected to propel the growth of the intranasal drug delivery device market going forward. Non-invasive drug delivery refers to the administration of pharmaceutical substances into the body without the need for penetration or incision of the skin or mucous membranes. Non-invasive drug delivery uses intranasal drug delivery devices to make IT easy and effective to give drugs through the nose. These devices take advantage of the nose's large blood vessel network and fast absorption, which improves drug bioavailability and patient adherence while reducing the need for invasive procedures. For instance, in August 2023, according to The Aesthetic Society, a US-based medical society, in the U.S., nonsurgical procedures saw a substantial increase, with body contouring, skin treatment, toxins, and micro needling showing growth rates of 31%, 26%, 24%, and 23%, respectively in 2022. Therefore, the growing demand for non-invasive drug delivery methods is driving the growth of the intranasal drug delivery device market.

Global Intranasal Drug Delivery Devices Market Major Players

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

Global Intranasal Drug Delivery Devices Market Trend: Innovative Intranasal Drug Delivery Technology

Major pharmaceutical companies operating in the nasal drug delivery technology market are involved in developing new and improved products to provide their customers with new methods of drug administration to sustain their position in the market. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, launched the first recyclable, metal-free, multidose nasal spray, APF Futurity, to deliver nasal saline and other equivalent over-the-counter (OTC) formulations. APF Futurity is manufactured from polyolefin materials and does not include any metal components or recycling disruptors. This reduces the need for separation in recycling streams and promotes a greater grade of recycled materials. This product's unique feature is its recyclability design; IT is a highly recyclable nasal spray pump that has received Class AA certification from cyclos-HTP for recycling streams in Europe.

Intranasal Drug Delivery Devices Market Merger And Acquisition: Sandoz AG Strengthens Inhalation Drug Delivery Portfolio With Acquisition Of Coalesce Product Development Limited

In March 2022, Sandoz AG, a Switzerland-based biopharmaceutical company (a division of the Novartis Group), acquired Coalesce Product Development Limited for an undisclosed amount. With this acquisition, Sandoz aims to expand its capabilities in inhalation drug delivery, add a commercial-stage product to its portfolio, and accelerate the development and commercialization of intranasal drug delivery devices. Coalesce Product Development Limited is a UK-based drug delivery device development company, including nasal drug delivery.

Regional Outlook For The Global Intranasal Drug Delivery Devices Market

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intranasal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Intranasal Drug Delivery Devices Market?

The intranasal drug delivery devices market consists of sales of nasal sprays, nasal powder devices, nasal antipsychotic medications, nasal epinephrine devices, nasal drops, and nasal inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Intranasal Drug Delivery Devices Industry?

The intranasal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides intranasal drug delivery devices market statistics, including intranasal drug delivery devices industry global market size, regional shares, competitors with a intranasal drug delivery devices market share, detailed intranasal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal drug delivery devices industry. This intranasal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Intranasal Drug Delivery Devices Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $65.59 billion
Revenue Forecast In 2034 $92.05 billion
Growth Rate CAGR of 8.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users Subsegments: 1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Intranasal Drug Delivery Devices Market Characteristics

    3. Intranasal Drug Delivery Devices Market Trends And Strategies

    4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Intranasal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

    5.1. Global Intranasal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Intranasal Drug Delivery Devices Market Growth Rate Analysis

    5.4. Global Intranasal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Intranasal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Intranasal Drug Delivery Devices Total Addressable Market (TAM)

    6. Intranasal Drug Delivery Devices Market Segmentation

    6.1. Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Powder Delivery Device

    Liquid Delivery Device

    Pressurized Metered-Dose Inhalers

    Other Products

    6.2. Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Unit-Dose

    Multi-Dose

    6.3. Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Chronic Obstructive Pulmonary Disease (COPD)

    Rhinitis

    Cystic Fibrosis

    Nasal Congestion

    Asthma

    Other Applications

    6.4. Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Homecare

    Other End Users

    6.5. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Single-Dose Powder Device

    Multi-Dose Powder Device

    6.6. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Single-Dose Liquid Device

    Multi-Dose Liquid Device

    6.7. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers (pMDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Breath-Actuated PMDIs

    Conventional pMDIs

    6.8. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Gel Delivery Device

    Nebulizers

    Nasal Sprays

    7. Intranasal Drug Delivery Devices Market Regional And Country Analysis

    7.1. Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Intranasal Drug Delivery Devices Market

    8.1. Asia-Pacific Intranasal Drug Delivery Devices Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Intranasal Drug Delivery Devices Market

    9.1. China Intranasal Drug Delivery Devices Market Overview

    9.2. China Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Intranasal Drug Delivery Devices Market

    10.1. India Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Intranasal Drug Delivery Devices Market

    11.1. Japan Intranasal Drug Delivery Devices Market Overview

    11.2. Japan Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Intranasal Drug Delivery Devices Market

    12.1. Australia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Intranasal Drug Delivery Devices Market

    13.1. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Intranasal Drug Delivery Devices Market

    14.1. South Korea Intranasal Drug Delivery Devices Market Overview

    14.2. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Intranasal Drug Delivery Devices Market

    15.1. Western Europe Intranasal Drug Delivery Devices Market Overview

    15.2. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Intranasal Drug Delivery Devices Market

    16.1. UK Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Intranasal Drug Delivery Devices Market

    17.1. Germany Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Intranasal Drug Delivery Devices Market

    18.1. France Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Intranasal Drug Delivery Devices Market

    19.1. Italy Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Intranasal Drug Delivery Devices Market

    20.1. Spain Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Intranasal Drug Delivery Devices Market

    21.1. Eastern Europe Intranasal Drug Delivery Devices Market Overview

    21.2. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Intranasal Drug Delivery Devices Market

    22.1. Russia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Intranasal Drug Delivery Devices Market

    23.1. North America Intranasal Drug Delivery Devices Market Overview

    23.2. North America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Intranasal Drug Delivery Devices Market

    24.1. USA Intranasal Drug Delivery Devices Market Overview

    24.2. USA Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Intranasal Drug Delivery Devices Market

    25.1. Canada Intranasal Drug Delivery Devices Market Overview

    25.2. Canada Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Intranasal Drug Delivery Devices Market

    26.1. South America Intranasal Drug Delivery Devices Market Overview

    26.2. South America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Intranasal Drug Delivery Devices Market

    27.1. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Intranasal Drug Delivery Devices Market

    28.1. Middle East Intranasal Drug Delivery Devices Market Overview

    28.2. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Intranasal Drug Delivery Devices Market

    29.1. Africa Intranasal Drug Delivery Devices Market Overview

    29.2. Africa Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Intranasal Drug Delivery Devices Market Competitive Landscape And Company Profiles

    30.1. Intranasal Drug Delivery Devices Market Competitive Landscape

    30.2. Intranasal Drug Delivery Devices Market Company Profiles

    30.2.1. Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

    31. Intranasal Drug Delivery Devices Market Other Major And Innovative Companies

    31.1. 3M Company

    31.2. Becton, Dickinson and Company

    31.3. Teva Pharmaceutical Industries Ltd.

    31.4. AptarGroup Inc.

    31.5. West Pharmaceutical Services Inc.

    31.6. Teleflex Incorporated

    31.7. Recipharm AB

    31.8. Nemera Development S.A.

    31.9. Consort Medical plc.

    31.10. Vectura Group plc

    31.11. Douglas Pharmaceuticals Ltd.

    31.12. Avanir Pharmaceuticals

    31.13. OptiNoset Inc.

    31.14. Flamel Technologies

    31.15. Aegis Therapeutics LLC

    32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

    34. Recent Developments In The Intranasal Drug Delivery Devices Market

    35. Intranasal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

    35.1 Intranasal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities

    35.2 Intranasal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities

    35.3 Intranasal Drug Delivery Devices Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers (pMDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Johnson and Johnson Inc. Financial Performance
  • Table 80: Merck and Co. Inc. Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: AstraZeneca plc. Financial Performance
  • Table 83: GlaxoSmithKline Plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers (pMDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Johnson and Johnson Inc. Financial Performance
  • Figure 80: Merck and Co. Inc. Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: AstraZeneca plc. Financial Performance
  • Figure 83: GlaxoSmithKline Plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Intranasal Drug Delivery Devices market?

Intranasal drug delivery devices are medical devices that deliver medications into the nasal cavity. These devices are intended to administer medications directly to the nasal mucosa, which is highly vascularized and has a huge surface area, allowing the drug to be absorbed into the bloodstream quickly. It delivers drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity. For further insights on the Intranasal Drug Delivery Devices market, request a sample here

How will the Intranasal Drug Delivery Devices market drivers and restraints affect the market dynamics? What forces will shape the Intranasal Drug Delivery Devices industry going forward?

The Intranasal Drug Delivery Devices market major growth driver - Rising Prevalence of Chronic Diseases Fuels Growth In The Intranasal Drug Delivery Devices Market. For further insights on the Intranasal Drug Delivery Devices market, request a sample here

What is the forecast market size or the forecast market value of the Intranasal Drug Delivery Devices market?

The Intranasal Drug Delivery Devices market size has grown strongly in recent years. The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $60.27 billion in 2024 to $65.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, market expansion in allergic rhinitis treatment, wider range of indications. The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $92.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, market penetration in emerging economies. Major trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, incorporation of biologics and peptides. For further insights on the Intranasal Drug Delivery Devices market, request a sample here

How is the Intranasal Drug Delivery Devices market segmented?

The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays For further insights on the Intranasal Drug Delivery Devices market,
request a sample here

Which region has the largest share of the Intranasal Drug Delivery Devices market? What are the other regions covered in the report?

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Intranasal Drug Delivery Devices market, request a sample here.

Who are the major players in the Intranasal Drug Delivery Devices market?

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation. For further insights on the Intranasal Drug Delivery Devices market, request a sample here.

What are the key trends in the Intranasal Drug Delivery Devices market?

Major trends in the Intranasal Drug Delivery Devices market include Innovative Intranasal Drug Delivery Technology. For further insights on the Intranasal Drug Delivery Devices market, request a sample here.

What are the major opportunities in the Intranasal Drug Delivery Devices market? What are the strategies for the Intranasal Drug Delivery Devices market?

For detailed insights on the major opportunities and strategies in the Intranasal Drug Delivery Devices market, request a sample here.

How does the Intranasal Drug Delivery Devices market relate to the overall economy and other similar markets?

For detailed insights on Intranasal Drug Delivery Devices's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Intranasal Drug Delivery Devices industry?

For detailed insights on the mergers and acquisitions in the Intranasal Drug Delivery Devices industry, request a sample here.

What are the key dynamics influencing the Intranasal Drug Delivery Devices market growth? SWOT analysis of the Intranasal Drug Delivery Devices market.

For detailed insights on the key dynamics influencing the Intranasal Drug Delivery Devices market growth and SWOT analysis of the Intranasal Drug Delivery Devices industry, request a sample here.